Actemra Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

An Open-Label, Multicenter Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab in Combination With Tiragolumab With or Without Atezolizumab in Participants With B-Cell Non-Hodgkin Lymphoma
Condition:   Non-Hodgkin Lymphoma, Follicular Lymphoma Interventions:   Drug: Mosunetuzumab SC;   Drug: Tiragolumab;   Drug: Atezolizumab;   Other: Tocilizumab Sponsor:   Hoffmann-La Roche Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 7, 2022 Category: Research Source Type: clinical trials

Combination of Inhaled DNase, Baricitinib and Tocilizumab in Severe COVID-19
Condition:   COVID-19 Severe Respiratory Failure Interventions:   Drug: Dexamethasone;   Drug: Low molecular weight heparin;   Drug: Anakinra 100Mg/0.67Ml Inj Syringe;   Drug: Tocilizumab;   Drug: Baricitinib;   Drug: Dornase Alfa Inhalant Product Sponsor:   Democritus University of Thrace Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2022 Category: Research Source Type: clinical trials